Browse all categories:

2019: A year of expansion in psychedelic research, industry, and deregulation

Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on  …


Study Drug Sessions - Sex, sexuality and body image

In July 2020, Drug Science launched the Medical Psychedelics Working Group (MPWG) – a consortium of experts, leading researchers and policy specialists. The overarching goal of this group is to create a rational and enlightened approach to psychedelic research and clinical treatment. To achieve this, education and destigmatisation will be critical in changing the public’s  …


How has COVID-19 affected drug use?

COVID-19 has changed our lives: from travel bans, social and physical isolation and empty cities to workers laid off and governments scrambling to muster effective responses. The impact that coronavirus has had on people varies widely and differently between countries. Relationships may be placed under new stresses and for those educating children at home, long  …


Putting UK Drug Policy into Focus

Commentary on the short film ‘Putting UK Drug Policy into Focus’ and reflections on the morality of a criminal justice approach to drugs A short film has been produced that explores some of the misconceptions fuelling the propagation of punitive drug policy, and what an alternative approach to drugs might look like. The film features  …


Clinical Insights - Psilocybin for Anorexia Nervosa

In July 2020, Drug Science launched the Medical Psychedelics Working Group (MPWG) – a consortium of experts, leading researchers and policy specialists. The overarching goal of this group is to create a rational and enlightened approach to psychedelic research and clinical treatment. To achieve this, education and destigmatisation will be critical in changing the public’s  …


Drug Science is Hiring - Communications Director

Job brief We are looking for a Communications Director to join our core team. We are in an exciting stage of growth as an organisation, one that will reward initiative and a growth mindset with opportunities for fast career development. We are looking for a talented communicator who thrives off translating the scientific evidence-base for  …


Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …


The Cannabis Society: London Medical Cannabis Conference

Drug Science is delighted to support The Cannabis Society Medical Conference, being held on 24th June in Central London. The Cannabis Society is dedicated to fostering the cannabis community through events, conferences, dinners and much more. The conference is an opportunity to join with doctors from both Europe and North America, industry experts, investors and  …


DrugScience Symposium 'Cannabis medicines: from principle to practice. How can we maximise clinical research and benefits?'

Please download the conference background materials here, including: Meeting slides DrugScience report on medicinal cannabis DrugScience cannabis pre-review submitted to the WHO Expert Committee on Drug Dependence Summaries of international and American medicinal cannabis licensing The Chief Medical Officer and advisor to the UK government has recently agreed that cannabis is a medicine. It has  …

The Unintended Consequences of Prohibitionist Policies - Mephedrone

Mephedrone is the common name for 4-methylmethcathinone. This is a synthetic derivative of cathinone, first synthesized in 1929, and largely forgotten until the early 2000s when Israeli scientists working for an insecticide company started experimenting with cathinones as octopamine analogues to disrupt the brain activity of aphids so make them less damaging to plants. Mephedrone  …


THC vs Alcohol Impaired Driving

By Dr. Shanna Marrinan   Since the 2nd of March 2015, it has been illegal to drive with predetermined amounts of particular drugs (including legal medications) in your blood. The limits for these legal and illegal drugs can be located in ‘The Drug Driving (Specified Limits) (England and Wales) Regulations 2014’ (hereafter the 2014 regulations’). However, a handy  …


The vaping crisis - Questions and answers by Clive Bates 

Foreword by Professor David Nutt Lies, damn lies and vaping statistics- To paraphrase Disraeli’s famous critique of statistics the so-called science of vaping now seems to have become even worse than dishonest. In the past 6 months we have seen across the world a deliberate attempt to mislead the public over the harms of vaping  …


UK General Election 2019 - Political party positions on drugs

With the 2019 general election fast approaching, a lot of media coverage will focus on each party’s Brexit policies. Drug Science would like to offer a different perspective, what do the six highest polling parties promise to do to address the UK’s failing drug policy. This is what each party has publicly announced relating to  …


The human rights of people who use drugs must be defended

The Lancet has recently published a series of articles about drug use. More specifically, the use of opioids, cannabinoids, stimulants, and new psychoactive substances (NPS). One of these articles highlights an increasingly relevant issue of international drug policy. This comment titled Change But Not Progression, emphasises that Governments around the world continue to pedal policies  …